Advancing Tomorrow's Medicines - Overcoming the Manufacturing Challenges Today by Steve Bagshaw, CEng, FIChemE, Chief Operating Officer, Fujifilm Diosynth Biotechnologies
Innovation in Transformative Medicine: What’s Changing the Bioprocessing Landscape by Eric Langer, President & Managing Partner, BioPlan Associates, Inc.
mRNA Medicines – Industrializing a New Platform by Juan Andres, Chief Technical Operations and Quality Officer, Moderna, Inc.
The day continued with the Exhibit Hall opening where attendees were able to take advantage of connecting with companies showcasing the latest in technology relevant to the biopharmaceutical manufacturing industry.
Follow the hashtag #ISPEBio on LinkedIn and Twitter to stay up to date on what is going on throughout the conference.
ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
Pfizer Asia Pacific Manufacturing Ltd has been honored with the 2024 ISPE Facility of the Year Award (FOYA) Category Award Operations in Project Execution. This prestigious award recognizes the outstanding efforts behind the Pfizer API Facility Extension, commonly referred to as Tuas 2, located in Tuas, Singapore.
As with all aspects of our life sciences industry, understanding how we can best meet the needs of patients with the timely delivery of life saving and sustaining products is of paramount concern. During the years since the global pandemic, the expectations and pressures on the pharmaceutical industry with respect to development, speed to market, quality and sustainability have increased...
At the 2024 ISPE Europe Annual Conference, held in Lisbon, Portugal, 16-18 April, Richard L. Friedman, MS, Deputy Director of the US Food and Drug Administration’s (US FDA) Office of Manufacturing Quality, in...